NCT04406168

Brief Summary

Radical cystectomy (RC) for bladder cancer requires reconstruction of the lower urinary tract. Both continent and incontinent diversions are available for urinary reconstruction after RC. Types of urinary diversions include ( ileal conduit, uretero-cutaneous, ureterosigmoidostomy and orthotopic bladder) The decision process is complex and involves consideration of issues related to cancer stage, patient comorbidities, treatment needs, and patient desires related to Quality of life and intraoperative findings. Outcomes of urinary diversions include 1- survival rate (cancer specific or overall survival). 2- Oncological failure (local, distant or LNs). 3- Complications (perioperative, intraoperative or post-operative). In this study, all these outcomes will be analyzed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 28, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

May 28, 2020

Status Verified

May 1, 2020

Enrollment Period

1.9 years

First QC Date

May 10, 2020

Last Update Submit

May 27, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Rate of patients presented by complications

    such as (change from baseline of the SCR - urinary tract infections - stone formation - stricture at site of anastomosis or stromal stenosis )

    1 year post operative

  • Rate of patients developed recurrence

    recurrence of cancer

    1 year post operative

  • Survival rate (overall survival & cancer specific)

    patient live post operative

    1 year post operative

Interventions

follow up outcomes of urinary diversion

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All cases that fulfil the selection criteria that have been admitted in Asyut university urology hospital (non probability sample size) with expected size of 40 patients starting from 01/01/2013 to1/05/2020. Additionally, the competence of follow-up will be approved by imaging and medical records.

You may qualify if:

  • \* All patients underwent radical cystectomy more than 1 year

You may not qualify if:

  • incomplete data
  • patients underwent RC outside urology department and presented for treatment of complications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Elgam3a, 11174, Egypt

RECRUITING

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Interventions

Urinary Diversion

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Urologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • salah s abdelhafez

    prof

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident of urology

Study Record Dates

First Submitted

May 10, 2020

First Posted

May 28, 2020

Study Start

June 1, 2020

Primary Completion

May 1, 2022

Study Completion

May 1, 2023

Last Updated

May 28, 2020

Record last verified: 2020-05

Locations